Repligen (RGEN) Tops Q4 EPS by 16c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $132.02 --0%
Revenue Growth %: +10.7%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +10.7%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.81, $0.16 better than the analyst estimate of $0.65. Revenue for the quarter came in at $186.5 million versus the consensus estimate of $179.29 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.21-$3.30, versus the consensus of $3.15. Repligen sees FY2022 revenue of $800-830 million, versus the consensus of $801.46 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
- CRH agrees to buy Arcosa in $8.5B all-cash deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
